Published in J Pharm Sci on February 22, 2012
Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties. AIDS Res Hum Retroviruses (2013) 1.04
Combinations of griffithsin with other carbohydrate-binding agents demonstrate superior activity against HIV Type 1, HIV Type 2, and selected carbohydrate-binding agent-resistant HIV Type 1 strains. AIDS Res Hum Retroviruses (2012) 0.93
Vaginal deployment and tenofovir delivery by microbicide gels. Drug Deliv Transl Res (2015) 0.89
Development and evaluation of a thermosensitive vaginal gel containing raltegravir+efavirenz loaded nanoparticles for HIV prophylaxis. Antiviral Res (2012) 0.87
Vaginal drug distribution modeling. Adv Drug Deliv Rev (2015) 0.83
Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir. Mol Pharm (2014) 0.81
Characterization of UC781-tenofovir combination gel products for HIV-1 infection prevention in an ex vivo ectocervical model. Antimicrob Agents Chemother (2012) 0.81
Potential role of tenofovir vaginal gel for reduction of risk of herpes simplex virus in females. Int J Womens Health (2012) 0.81
Evaluation of Rapidly Disintegrating Vaginal Tablets of Tenofovir, Emtricitabine and Their Combination for HIV-1 Prevention. Pharmaceutics (2014) 0.80
Modified silicone elastomer vaginal gels for sustained release of antiretroviral HIV microbicides. J Pharm Sci (2014) 0.77
Development of polyether urethane intravaginal rings for the sustained delivery of hydroxychloroquine. Drug Des Devel Ther (2014) 0.77
Does tenofovir gel or do other microbicide products affect detection of biomarkers of semen exposure in vitro? Contraception (2014) 0.76
Perceptibility and the "Choice Experience": User Sensory Perceptions and Experiences Inform Vaginal Prevention Product Design. AIDS Res Hum Retroviruses (2016) 0.75
Assessment of a Microbicide Candidate among a Diverse Cohort of Urban Southern US Women and their Male Sexual Partners. J AIDS Clin Res (2012) 0.75
Mortality in Emergency Department Sepsis (MEDS) score: a prospectively derived and validated clinical prediction rule. Crit Care Med (2003) 4.25
A stapled BID BH3 helix directly binds and activates BAX. Mol Cell (2006) 3.86
Biological and structural characterization of a host-adapting amino acid in influenza virus. PLoS Pathog (2010) 3.65
The transcriptional coactivator PGC-1beta drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab (2007) 3.05
Evolving protein interaction networks through gene duplication. J Theor Biol (2003) 2.98
Immune activation in patients with irritable bowel syndrome. Gastroenterology (2007) 2.82
An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell (2011) 2.49
A review of the physical and chemical properties of human semen and the formulation of a semen simulant. J Androl (2005) 2.07
Enhancement and diversification of IFN induction by IRF-7-mediated positive feedback. J Interferon Cytokine Res (2002) 1.68
Squeezing flows of vaginal gel formulations relevant to microbicide drug delivery. J Biomech Eng (2006) 1.60
Segmented polyurethane intravaginal rings for the sustained combined delivery of antiretroviral agents dapivirine and tenofovir. Eur J Pharm Sci (2009) 1.58
IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff. Nat Cell Biol (2002) 1.51
Tissue-specific positive feedback requirements for production of type I interferon following virus infection. J Biol Chem (2005) 1.50
Off-hour admission and in-hospital stroke case fatality in the get with the guidelines-stroke program. Stroke (2008) 1.48
Endocardial electrogram characteristics of epicardial ventricular arrhythmias. J Cardiovasc Electrophysiol (2013) 1.39
Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring. Antimicrob Agents Chemother (2011) 1.38
Gravity-induced coating flows of vaginal gel formulations: in vitro experimental analysis. J Pharm Sci (2004) 1.38
Dilution of microbicide gels with vaginal fluid and semen simulants: effect on rheological properties and coating flow. J Pharm Sci (2008) 1.37
Bicoid cooperative DNA binding is critical for embryonic patterning in Drosophila. Proc Natl Acad Sci U S A (2005) 1.36
Quantitative model of price diffusion and market friction based on trading as a mechanistic random process. Phys Rev Lett (2003) 1.35
Spatial analysis of prostate cancer incidence and race in Virginia, 1990-1999. Am J Prev Med (2006) 1.33
A model of transluminal flow of an anti-HIV microbicide vehicle: Combined elastic squeezing and gravitational sliding. Phys Fluids (1994) (2008) 1.31
Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory. Biophys J (2006) 1.31
Reliability of a novel classification system for thoracolumbar injuries: the Thoracolumbar Injury Severity Score. Spine (Phila Pa 1976) (2006) 1.30
Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked Hydrogel. Adv Funct Mater (2009) 1.28
Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets. Antiviral Res (2010) 1.24
Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state. J Cell Sci (2013) 1.24
The Toxicology Investigators Consortium Case Registry--the 2012 experience. J Med Toxicol (2013) 1.21
Design of a semisolid vaginal microbicide gel by relating composition to properties and performance. Pharm Res (2010) 1.19
An intravaginal ring for the simultaneous delivery of multiple drugs. J Pharm Sci (2012) 1.17
Evaluation of a pressure walkway system for measurement of vertical limb forces in clinically normal dogs. Am J Vet Res (2006) 1.17
A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis. Antimicrob Agents Chemother (2012) 1.16
The emergence and early evolution of biological carbon-fixation. PLoS Comput Biol (2012) 1.16
Interpreting properties of microbicide drug delivery gels: analyzing deployment kinetics due to squeezing. J Pharm Sci (2007) 1.15
Optical imaging and analysis of human vaginal coating by drug delivery gels. Contraception (2006) 1.10
Compartmental transport model of microbicide delivery by an intravaginal ring. J Pharm Sci (2010) 1.09
Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b. Toxicol Sci (2011) 1.09
Acute operative stabilization versus nonoperative management of clavicle fractures. Am J Orthop (Belle Mead NJ) (2009) 1.08
The effects of inhomogeneous boundary dilution on the coating flow of an anti-HIV microbicide vehicle. Phys Fluids (1994) (2011) 1.08
Erosion of microbicide formulation coating layers: effects of contact and shearing with vaginal fluid or semen. J Pharm Sci (2005) 1.08
Transient spreading and swelling behavior of a gel deploying an anti-HIV topical microbicide. J Nonnewton Fluid Mech (2012) 1.07
Acetylation of interferon regulatory factor-7 by p300/CREB-binding protein (CBP)-associated factor (PCAF) impairs its DNA binding. J Biol Chem (2002) 1.05
Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies. Int J Womens Health (2013) 1.05
Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties. AIDS Res Hum Retroviruses (2013) 1.04
Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines. Antiviral Res (2010) 1.04
A mechanism for the association of amino acids with their codons and the origin of the genetic code. Proc Natl Acad Sci U S A (2005) 1.02
A hot-melt extruded intravaginal ring for the sustained delivery of the antiretroviral microbicide UC781. J Pharm Sci (2011) 1.01
Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma. Oncol Rep (2009) 1.01
The origin of the RNA world: co-evolution of genes and metabolism. Bioorg Chem (2007) 1.01
Multipurpose prevention technologies: products in development. Antiviral Res (2013) 1.00
Multipurpose prevention technologies: biomedical tools to prevent HIV-1, HSV-2, and unintended pregnancies. Infect Dis Obstet Gynecol (2011) 1.00
"Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels. AIDS Behav (2014) 1.00
Genetically driven target tissue overexpression of CD40: a novel mechanism in autoimmune disease. J Immunol (2012) 0.99
Temperature and pH sensitive hydrogels: an approach towards smart semen-triggered vaginal microbicidal vehicles. J Pharm Sci (2007) 0.97
Transport theory for HIV diffusion through in vivo distributions of topical microbicide gels. Biophys J (2009) 0.97
The consequences of yield stress on deployment of a non-Newtonian anti-HIV microbicide gel. J Nonnewton Fluid Mech (2011) 0.95
Reflections on CASA after 25 years. J Androl (2004) 0.95
Preclinical evaluation of anti-HIV microbicide products: New models and biomarkers. Antiviral Res (2010) 0.94
User-identified gel characteristics: a qualitative exploration of perceived product efficacy of topical vaginal microbicides. Arch Sex Behav (2014) 0.93
Biophysical analysis of prototype microbicidal gels. J Pharm Sci (2007) 0.93
Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention. Antiviral Res (2012) 0.93
Transient swelling, spreading, and drug delivery by a dissolved anti-HIV microbicide-bearing film. Phys Fluids (1994) (2013) 0.92
Ligand field theory and the origin of life as an emergent feature of the periodic table of elements. Biol Bull (2010) 0.92
Identification of age-specific Nrf2 binding to a novel antioxidant response element locus in the Gclc promoter: a compensatory means for the loss of glutathione synthetic capacity in the aging rat liver? Aging Cell (2012) 0.91
The compositional and evolutionary logic of metabolism. Phys Biol (2012) 0.91
Effect of temperature and pH on contraceptive gel viscosity. Contraception (2003) 0.91
Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits. AIDS Res Hum Retroviruses (2012) 0.90
Semi-solid gels function as physical barriers to human immunodeficiency virus transport in vitro. Antiviral Res (2010) 0.90
The stochastic behavior of a molecular switching circuit with feedback. Biol Direct (2007) 0.90
Pharmacokinetic and safety analyses of tenofovir and tenofovir-emtricitabine vaginal tablets in pigtailed macaques. Antimicrob Agents Chemother (2014) 0.89
A comparison of primary oesophageal squamous epithelial cells with HET-1A in organotypic culture. Biol Cell (2010) 0.89
Rapid-prototyped PLGA/β-TCP/hydroxyapatite nanocomposite scaffolds in a rabbit femoral defect model. Biofabrication (2012) 0.88
Multicompartmental pharmacokinetic model of tenofovir delivery by a vaginal gel. PLoS One (2013) 0.88
Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia. Neuropsychiatr Dis Treat (2009) 0.88
Prenatal diagnosis of sex differentiation disorders: the role of fetal ultrasound. J Clin Endocrinol Metab (2002) 0.88
Measuring macrodiffusion coefficients in microbicide hydrogels via postphotoactivation scanning. Biomacromolecules (2008) 0.87
Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir. J Control Release (2012) 0.87
Effect of catheter movement and contact during application of radiofrequency energy on ablation lesion characteristics. J Interv Card Electrophysiol (2013) 0.86